{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:14:00Z","timestamp":1783685640575,"version":"3.55.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek Vlaanderen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ymgme.2024.108434","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T08:16:48Z","timestamp":1709626608000},"page":"108434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Glycosphingolipids in congenital disorders of glycosylation (CDG)"],"prefix":"10.1016","volume":"142","author":[{"given":"Andrea","family":"J\u00e1\u00f1ez Pedrayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Rymen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Ghesqui\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Witters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ymgme.2024.108434_bb0005","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","article-title":"Global view of human protein glycosylation pathways and functions","volume":"21","author":"Schjoldager","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0304-4165(99)00165-8","article-title":"On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database","volume":"1473","author":"Apweiler","year":"1999","journal-title":"Biochim. Biophys. Acta BBA."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1203\/00006450-198002000-00117","article-title":"Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase a and increased CSF protein: a new syndrome?: 90","volume":"14","author":"Jaeken","year":"1980","journal-title":"Pediatr. Res."},{"issue":"2\u20133","key":"10.1016\/j.ymgme.2024.108434_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0009-8981(84)90059-7","article-title":"Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome","volume":"144","author":"Jaeken","year":"1984","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13023-023-02879-z","article-title":"Congenital disorders of glycosylation (CDG): state of the art in 2022","volume":"18","author":"Francisco","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/brainsci11010088","article-title":"Congenital disorders of glycosylation from a neurological perspective","volume":"11","author":"Paprocka","year":"2021","journal-title":"Brain Sci."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108434_bb0035","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1021\/acschembio.1c00601","article-title":"Chemical therapies for congenital disorders of glycosylation","volume":"17","author":"Sosicka","year":"2022","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108434_bb0040","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/jimd.12289","article-title":"Long term outcome of MPI-CDG patients on D-mannose therapy","volume":"43","author":"Girard","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108434_bb0045","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1651-2227.2002.tb00101.x","article-title":"Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency","volume":"91","author":"Harms","year":"2002","journal-title":"Acta Paediatr."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108434_bb0050","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1182\/blood.V94.12.3976","article-title":"Correction of leukocyte adhesion deficiency type II with Oral Fucose","volume":"94","author":"Marquardt","year":"1999","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ymgme.2024.108434_bb0055","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/ajmg.a.62737","article-title":"Defining the mild variant of leukocyte adhesion deficiency type II (SLC35C1 -congenital disorder of glycosylation) and response to L -fucose therapy: insights from two new families and review of the literature","volume":"188","author":"Tahata","year":"2022","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2024.108434_bb0060","article-title":"L-Fucose treatment of FUT8-CDG","volume":"25","author":"Park","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108434_bb0065","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ajhg.2019.03.003","article-title":"The metabolic map into the Pathomechanism and treatment of PGM1-CDG","volume":"104","author":"Radenkovic","year":"2019","journal-title":"Am. J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108434_bb0070","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/gim.2017.41","article-title":"Oral D-galactose supplementation in PGM1-CDG","volume":"19","author":"Wong","year":"2017","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108434_bb0075","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10545-015-9828-6","article-title":"A new case of UDP-galactose transporter deficiency (SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach","volume":"38","author":"D\u00f6rre","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108434_bb0080","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41436-020-0767-8","article-title":"Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG","volume":"22","author":"Witters","year":"2020","journal-title":"Genet. Med."},{"issue":"24","key":"10.1016\/j.ymgme.2024.108434_bb0085","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1111\/febs.12559","article-title":"Glycosphingolipids: synthesis and functions","volume":"280","author":"D'Angelo","year":"2013","journal-title":"FEBS J."},{"issue":"23","key":"10.1016\/j.ymgme.2024.108434_bb0090","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.3390\/molecules25235755","article-title":"Nucleotide sugars in chemistry and biology","volume":"25","author":"Mikkola","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.biochem.67.1.49","article-title":"Transporters of nucleotide sugars, ATP, and nucleotide sulfate in the endoplasmic reticulum and Golgi apparatus","volume":"67","author":"Hirschberg","year":"1998","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108434_bb0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1042\/BJ20111626","article-title":"Ceramide synthases at the Centre of sphingolipid metabolism and biology","volume":"441","author":"Mullen","year":"2012","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/tra.12239","article-title":"Sphingolipid metabolism and Interorganellar transport: localization of sphingolipid enzymes and lipid transfer proteins","volume":"16","author":"Yamaji","year":"2015","journal-title":"Traffic"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0110","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1021\/bi00830a008","article-title":"Synthesis of cerebroside by brain from uridine diphosphate galactose and ceramide containing hydroxy fatty acid","volume":"8","author":"Morell","year":"1969","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108434_bb0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1471-4159.1966.tb06794.x","article-title":"The lipid composition of purified bovine brain myelin*","volume":"13","author":"Norton","year":"1966","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1471-4159.1982.tb10875.x","article-title":"Cerebroside sulfotransferase in Golgi-enriched fractions from rat brain","volume":"38","author":"Benjamins","year":"1982","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0125","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0021-9258(17)33945-5","article-title":"In vitro biosynthesis of sialosylgalactosylceramide (G7) by mouse brain microsomes","volume":"251","author":"Yu","year":"1976","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.ymgme.2024.108434_bb0130","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1016\/S0021-9258(18)91935-6","article-title":"Enzymatic synthesis of ceramide-glucose and ceramide-lactose by glycosyltransferases from embryonic chicken brain","volume":"243","author":"Basu","year":"1968","journal-title":"J. Biol. Chem."},{"issue":"7158","key":"10.1016\/j.ymgme.2024.108434_bb0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature06097","article-title":"Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide","volume":"449","author":"D'Angelo","year":"2007","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ymgme.2024.108434_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007545","article-title":"Lactosylceramide synthases encoded by B4galt5 and 6 genes are pivotal for neuronal generation and myelin formation in mice","volume":"14","author":"Yoshihara","year":"2018","journal-title":"PLoS Genet."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108434_bb0145","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1021\/cr2002917","article-title":"Sphingolipid and glycosphingolipid metabolic pathways in the era of Sphingolipidomics","volume":"111","author":"Merrill","year":"2011","journal-title":"Chem. Rev."},{"issue":"20","key":"10.1016\/j.ymgme.2024.108434_bb0150","doi-asserted-by":"crossref","first-page":"15152","DOI":"10.1074\/jbc.M909620199","article-title":"Molecular cloning of Globotriaosylceramide\/CD77 synthase, a glycosyltransferase that initiates the synthesis of Globo series glycosphingolipids","volume":"275","author":"Kojima","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.ymgme.2024.108434_bb0155","doi-asserted-by":"crossref","first-page":"22032","DOI":"10.1074\/jbc.M011369200","article-title":"Molecular Cloning and Characterization of UDP-GlcNAc:Lactosylceramide \u03b21,3-N-Acetylglucosaminyltransferase (\u03b23Gn-T5), an Essential Enzyme for the Expression of HNK-1 and Lewis X Epitopes on Glycolipids","volume":"276","author":"Togayachi","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.ymgme.2024.108434_bb0160","doi-asserted-by":"crossref","first-page":"12082","DOI":"10.1016\/S0021-9258(19)49809-8","article-title":"Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides","volume":"267","author":"Nagata","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"48","key":"10.1016\/j.ymgme.2024.108434_bb0165","doi-asserted-by":"crossref","first-page":"31652","DOI":"10.1074\/jbc.273.48.31652","article-title":"Expression cloning and functional characterization of human cDNA for ganglioside GM3 synthase","volume":"273","author":"Ishii","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108434_bb0170","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5650\/jos.60.537","article-title":"Structures, biosynthesis, and functions of gangliosides-an overview","volume":"60","author":"Yu","year":"2011","journal-title":"J. Oleo Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0005-2760(73)90055-6","article-title":"A new procedure for the extraction, purification and fractionation of brain gangliosides","volume":"296","author":"Tettamanti","year":"1973","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","article-title":"Membrane lipids: where they are and how they behave","volume":"9","author":"Van Meer","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108434_bb0185","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s11064-010-0360-7","article-title":"Remodeling of sphingolipids by plasma membrane associated enzymes","volume":"36","author":"Aureli","year":"2011","journal-title":"Neurochem. Res."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108434_bb0190","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","article-title":"The sphingolipid salvage pathway in ceramide metabolism and signaling","volume":"20","author":"Kitatani","year":"2008","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0195","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012836","article-title":"The rapidly evolving view of lysosomal storage diseases","volume":"13","author":"Parenti","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primer."},{"issue":"5961","key":"10.1016\/j.ymgme.2024.108434_bb0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.1174621","article-title":"Lipid rafts as a membrane-organizing principle","volume":"327","author":"Lingwood","year":"2010","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ymgme.2024.108434_bb0210","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.febslet.2009.12.010","article-title":"Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction","volume":"584","author":"Posse De Chaves","year":"2010","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108434_bb0215","doi-asserted-by":"crossref","first-page":"a004788","DOI":"10.1101\/cshperspect.a004788","article-title":"Glycosphingolipid functions","volume":"3","author":"Lingwood","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108434_bb0220","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1172\/JCI116374","article-title":"Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function","volume":"91","author":"Holleran","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108434_bb0225","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1152\/physiol.00016.2009","article-title":"Oligodendrocyte development and myelin biogenesis: parsing out the roles of glycosphingolipids","volume":"24","author":"Jackman","year":"2009","journal-title":"Physiology"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108434_bb0230","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/glia.20292","article-title":"Sulfatide is essential for the maintenance of CNS myelin and axon structure","volume":"53","author":"Marcus","year":"2006","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108434_bb0235","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0304-4165(02)00410-5","article-title":"Galactolipids are molecular determinants of myelin development and axo\u2013glial organization","volume":"1573","author":"Marcus","year":"2002","journal-title":"Biochim. Biophys. Acta BBA."},{"issue":"18","key":"10.1016\/j.ymgme.2024.108434_bb0240","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1523\/JNEUROSCI.19-18-07913.1999","article-title":"Negative regulation of oligodendrocyte differentiation by Galactosphingolipids","volume":"19","author":"Bansal","year":"1999","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0245","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1097-4652(200001)182:1<97::AID-JCP11>3.0.CO;2-Y","article-title":"Functional significance of globotriaosyl ceramide in interferon-\u03b12\/type 1 interferon receptor-mediated antiviral activity","volume":"182","author":"Khine","year":"2000","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108434_bb0250","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/cdd.2008.115","article-title":"The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligand","volume":"15","author":"Chakrabandhu","year":"2008","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108434_bb0255","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201797674","article-title":"Glycosphingolipid metabolic reprogramming drives neural differentiation","volume":"37","author":"Russo","year":"2018","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0260","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00033.2013","article-title":"Sialic acids in the brain: gangliosides and Polysialic acid in nervous system development, stability, disease, and regeneration","volume":"94","author":"Schnaar","year":"2014","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.abb.2004.02.019","article-title":"Glycolipid-mediated cell\u2013cell recognition in inflammation and nerve regeneration","volume":"426","author":"Schnaar","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108434_bb0270","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ymgme.2019.01.013","article-title":"Recessive GM3 synthase deficiency: natural history, biochemistry, and therapeutic frontier","volume":"126","author":"Bowser","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"24","key":"10.1016\/j.ymgme.2024.108434_bb0275","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.219204","article-title":"Glycosphingolipid metabolism in cell fate specification","volume":"131","author":"Russo","year":"2018","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108434_bb0280","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1111\/j.1471-4159.2007.04910.x","article-title":"Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains","volume":"103","author":"Ngamukote","year":"2007","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0285","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/hmg\/ddt434","article-title":"A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation","volume":"23","author":"Boccuto","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108434_bb0290","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1134\/S0006297909030018","article-title":"Ganglioside GM3 and its biological functions","volume":"74","author":"Prokazova","year":"2009","journal-title":"Biochem. Mosc."},{"issue":"50","key":"10.1016\/j.ymgme.2024.108434_bb0295","doi-asserted-by":"crossref","first-page":"18987","DOI":"10.1073\/pnas.0609281103","article-title":"Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor","volume":"103","author":"Yoon","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"34","key":"10.1016\/j.ymgme.2024.108434_bb0300","doi-asserted-by":"crossref","first-page":"13678","DOI":"10.1073\/pnas.0703650104","article-title":"Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance","volume":"104","author":"Kabayama","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108434_bb0305","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1093\/hmg\/ddv041","article-title":"Ganglioside GM3 is essential for the structural integrity and function of cochlear hair cells","volume":"24","author":"Yoshikawa","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108434_bb0310","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4161\/auto.27959","article-title":"Evidence for the involvement of GD3 ganglioside in autophagosome formation and maturation","volume":"10","author":"Matarrese","year":"2014","journal-title":"Autophagy"},{"issue":"13","key":"10.1016\/j.ymgme.2024.108434_bb0315","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1096\/fj.99-1028com","article-title":"GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion","volume":"14","author":"Rippo","year":"2000","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108434_bb0320","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.3390\/ijms24119558","article-title":"Ganglioside GM1 and the central nervous system","volume":"24","author":"Guo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108434_bb0325","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1046\/j.1471-4159.1997.68062348.x","article-title":"Ganglioside GM1 enhances induction by nerve growth factor of a putative dimer of TrkA","volume":"68","author":"Farooqui","year":"1997","journal-title":"J. Neurochem."},{"issue":"39","key":"10.1016\/j.ymgme.2024.108434_bb0330","doi-asserted-by":"crossref","first-page":"13246","DOI":"10.1523\/JNEUROSCI.1149-14.2014","article-title":"Ganglioside regulation of AMPA receptor trafficking","volume":"34","author":"Prendergast","year":"2014","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108434_bb0335","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.febslet.2009.10.011","article-title":"Brain gangliosides in axon\u2013myelin stability and axon regeneration","volume":"584","author":"Schnaar","year":"2010","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0340","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1073\/pnas.93.2.814","article-title":"Gangliosides are neuronal ligands for myelin-associated glycoprotein","volume":"93","author":"Yang","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108434_bb0345","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ymgme.2018.06.014","article-title":"Diseases of ganglioside biosynthesis: an expanding group of congenital disorders of glycosylation","volume":"124","author":"Trinchera","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0350","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-019-0339-z","article-title":"Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinsons disease","volume":"14","author":"Huebecker","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108434_bb0355","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1046\/j.1471-4159.1994.63051802.x","article-title":"Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years","volume":"63","author":"Svennerholm","year":"1994","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108434_bb0360","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ng1460","article-title":"Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase","volume":"36","author":"Simpson","year":"2004","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108434_bb0365","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/ejhg.2012.202","article-title":"Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency","volume":"21","author":"Fragaki","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.ymgme.2024.108434_bb0370","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/ajmg.a.37773","article-title":"GM3 synthase deficiency due to ST3GAL5 variants in two Korean female siblings: masquerading as Rett syndrome-like phenotype","volume":"170","author":"Lee","year":"2016","journal-title":"Am. J. Med. Genet. A"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108434_bb0375","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/glycob\/cwy112","article-title":"Total loss of GM3 synthase activity by a normally processed enzyme in a novel variant and in all ST3GAL5 variants reported to cause a distinct congenital disorder of glycosylation","volume":"29","author":"Indellicato","year":"2019","journal-title":"Glycobiology"},{"issue":"10","key":"10.1016\/j.ymgme.2024.108434_bb0380","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.bbagen.2017.05.025","article-title":"Gangliosides and hearing","volume":"1861","author":"Inokuchi","year":"2017","journal-title":"Biochim. Biophys. Acta BBA"},{"issue":"5","key":"10.1016\/j.ymgme.2024.108434_bb0385","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/cge.12703","article-title":"Early growth and development impairments in patients with ganglioside GM3 synthase deficiency: early growth and development impairments in patients with GM3 deficiency","volume":"89","author":"Wang","year":"2016","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0390","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/cbic.201200641","article-title":"Effect of ganglioside GM3 synthase gene knockout on the glycoprotein N -glycan profile of mouse embryonic fibroblast","volume":"14","author":"Nagahori","year":"2013","journal-title":"Chem Bio Chem."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108434_bb0395","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0304-4165(02)00403-8","article-title":"\u03b21,4-N-acetylgalactosaminyltransferase\u2014GM2\/GD2 synthase: a key enzyme to control the synthesis of brain-enriched complex gangliosides","volume":"1573","author":"Furukawa","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0400","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajhg.2013.05.006","article-title":"Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia","volume":"93","author":"Boukhris","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108434_bb0405","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/brain\/awt270","article-title":"Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis","volume":"136","author":"Harlalka","year":"2013","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ymgme.2024.108434_bb0410","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/cge.12312","article-title":"Novel B4GALNT1 mutations in a complicated form of hereditary spastic paraplegia","volume":"86","author":"Wakil","year":"2014","journal-title":"Clin. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108434_bb0415","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000156","article-title":"Febrile ataxia and myokymia broaden the SPG26 hereditary spastic paraplegia phenotype","volume":"3","author":"Dad","year":"2017","journal-title":"Neurol. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108434_bb0420","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3988\/jcn.2021.17.4.534","article-title":"A compound heterozygous pathogenic variant in B4GALNT1 is associated with axonal Charcot-Marie-tooth disease","volume":"17","author":"Hong","year":"2021","journal-title":"J. Clin. Neurol."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108434_bb0425","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/ajmg.a.62880","article-title":"Functional validation of novel variants in B4GALNT1 associated with early-onset complex hereditary spastic paraplegia with impaired ganglioside synthesis","volume":"188","author":"Alecu","year":"2022","journal-title":"Am. J. Med. Genet. A"},{"issue":"11","key":"10.1016\/j.ymgme.2024.108434_bb0430","doi-asserted-by":"crossref","first-page":"e3253","DOI":"10.1002\/jgm.3253","article-title":"A novel variant of ST3GAL3 causes non-syndromic autosomal recessive intellectual disability in Iranian patients","volume":"22","author":"Farajollahi","year":"2020","journal-title":"J. Gene Med."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108434_bb0435","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ajhg.2011.08.008","article-title":"ST3GAL3 mutations impair the development of higher cognitive functions","volume":"89","author":"Hu","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0440","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1111\/epi.12050","article-title":"West syndrome caused by ST3Gal-III deficiency","volume":"54","author":"Edvardson","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0445","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.2322","article-title":"Clinical report and genetic analysis of a Chinese patient with developmental and epileptic encephalopathy associated with novel biallelic variants in the ST3GAL3 gene","volume":"12","author":"Hu","year":"2023","journal-title":"Mol. Genet. Genomic Med."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0450","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/glycob\/cwz079","article-title":"A novel nonsense and inactivating variant of ST3GAL3 in two infant siblings suffering severe epilepsy and expressing circulating CA19.9","volume":"30","author":"Indellicato","year":"2020","journal-title":"Glycobiology"},{"issue":"8","key":"10.1016\/j.ymgme.2024.108434_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104250","article-title":"Phenotype of ST3GAL3 deficient patients: a case and review of the literature","volume":"64","author":"Khamirani","year":"2021","journal-title":"Eur. J. Med. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0460","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/epi4.12747","article-title":"The epilepsy phenotype of ST3GAL3 -related developmental and epileptic encephalopathy","volume":"8","author":"Whitney","year":"2023","journal-title":"Epilepsia Open."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108434_bb0465","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41431-018-0220-5","article-title":"A patient-specific induced pluripotent stem cell model for west syndrome caused by ST3GAL3 deficiency","volume":"26","author":"Van Diepen","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"issue":"45","key":"10.1016\/j.ymgme.2024.108434_bb0470","doi-asserted-by":"crossref","first-page":"44429","DOI":"10.1074\/jbc.M301609200","article-title":"The blood group P1 synthase gene is identical to the Gb3\/CD77 synthase gene","volume":"278","author":"Iwamura","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0475","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbrc.2016.01.017","article-title":"Human Gb3\/CD77 synthase reveals specificity toward two or four different acceptors depending on amino acid at position 211, creating Pk, P1 and NOR blood group antigens","volume":"470","author":"Kaczmarek","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108434_bb0480","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1111\/trf.12771","article-title":"A systematic study of single-nucleotide polymorphisms in the a 4 GALT gene suggests a molecular genetic basis for the P 1 \/ P 2 blood groups","volume":"54","author":"Lai","year":"2014","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108434_bb0485","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/trf.14515","article-title":"The differential expression of the blood group P1- A4GALT and P2-A4GALT alleles is stimulated by the transcription factor early growth response 1","volume":"58","author":"Yeh","year":"2018","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0490","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1111\/trf.16163","article-title":"Novel A4GALT gene variation with rare p phenotype in a compound heterozygous chinese individual","volume":"61","author":"Chen","year":"2021","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.ymgme.2024.108434_bb0495","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.1111\/trf.16649","article-title":"A novel P1PK allele in two Bangladeshi sisters with a history of spontaneous abortion: A4GALT*02N (951C)","volume":"61","author":"Floch","year":"2021","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108434_bb0500","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1537-2995.2007.01552.x","article-title":"Expression of a novel missense mutation found in the A4GALT gene of Amish individuals with the p phenotype","volume":"48","author":"Hellberg","year":"2008","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0505","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/trf.13804","article-title":"A novel mutation in A4GALT was identified in a Chinese individual with p phenotype","volume":"57","author":"Li","year":"2017","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.ymgme.2024.108434_bb0510","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1111\/trf.16576","article-title":"Novel A4GALT gene variation with rare p phenotype in a Chinese family","volume":"61","author":"Qiu","year":"2021","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.ymgme.2024.108434_bb0515","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/vox.13042","article-title":"Clinical consequences of the extremely rare anti-PP1Pk isoantibodies in pregnancy: a case series and review of the literature","volume":"116","author":"Di Ciaccio","year":"2021","journal-title":"Vox Sang."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108434_bb0520","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/trf.16384","article-title":"Multidisciplinary management of anti-PP1P k or anti-P alloimmunization during pregnancy: a new case with anti-P and a literature review","volume":"61","author":"L\u00e9pine","year":"2021","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0525","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/tme.12008","article-title":"Molecular basis for the p and P k phenotypes in three Chinese individuals","volume":"23","author":"Hong","year":"2013","journal-title":"Transfus. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108434_bb0530","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/tme.12544","article-title":"Multiple miscarriages in two sisters of Thai origin with the rare P k phenotype caused by a novel nonsense mutation at the B3GALNT1 locus","volume":"29","author":"Ricci Hagman","year":"2019","journal-title":"Transfus. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108434_bb0535","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1423-0410.1982.tb01083.x","article-title":"An inherited RBC characteristic, NOR, resulting in erythrocyte polyagglutination","volume":"42","author":"Harris","year":"1982","journal-title":"Vox Sang."},{"issue":"45","key":"10.1016\/j.ymgme.2024.108434_bb0540","doi-asserted-by":"crossref","first-page":"38220","DOI":"10.1074\/jbc.M112.408286","article-title":"A single point mutation in the gene encoding Gb3\/CD77 synthase causes a rare inherited Polyagglutination syndrome","volume":"287","author":"Suchanowska","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108434_bb0545","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41436-018-0301-4","article-title":"Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?","volume":"21","author":"Witters","year":"2019","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108434_bb0550","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1203\/00006450-200211000-00007","article-title":"Increased biosynthesis of glycosphingolipids in congenital disorder of glycosylation Ia (CDG-Ia) fibroblasts","volume":"52","author":"Sala","year":"2002","journal-title":"Pediatr. Res."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108434_bb0555","article-title":"Biometals and glycosylation in humans: congenital disorders of glycosylation shed lights into the crucial role of Golgi manganese homeostasis","volume":"1864","author":"Foulquier","year":"2020","journal-title":"Biochim. Biophys. Acta BBA."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0560","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajhg.2012.05.002","article-title":"TMEM165 deficiency causes a congenital disorder of glycosylation","volume":"91","author":"Foulquier","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108434_bb0565","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1210\/jc.2016-3443","article-title":"Galactose supplementation in patients with TMEM165-CDG rescues the glycosylation defects","volume":"102","author":"Morelle","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"20","key":"10.1016\/j.ymgme.2024.108434_bb0570","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.3390\/ijms21207635","article-title":"Dissecting Total plasma and protein-specific glycosylation profiles in congenital disorders of glycosylation","volume":"21","author":"Hipgrave Ederveen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108434_bb0575","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1212\/WNL.0b013e3182a08f53","article-title":"Intellectual disability and bleeding diathesis due to deficient CMP-sialic acid transport","volume":"81","author":"Mohamed","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ymgme.2024.108434_bb0580","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1002\/ajmg.a.38412","article-title":"Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1","volume":"173","author":"Ng","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0585","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/ijms22010304","article-title":"Novel insights into selected disease-causing mutations within the SLC35A1 gene encoding the CMP-sialic acid transporter","volume":"22","author":"Szulc","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2024.108434_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.668640","article-title":"NANS-CDG: delineation of the genetic, biochemical, and clinical Spectrum","volume":"12","author":"Den Hollander","year":"2021","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0595","doi-asserted-by":"crossref","first-page":"17079","DOI":"10.1038\/s41598-022-21751-x","article-title":"Clinical and molecular findings in three Japanese patients with N-acetylneuraminic acid synthetase-congenital disorder of glycosylation (NANS-CDG)","volume":"12","author":"Masunaga","year":"2022","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108434_bb0600","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ng.3578","article-title":"NANS-mediated synthesis of sialic acid is required for brain and skeletal development","volume":"48","author":"Van Karnebeek","year":"2016","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0605","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/ahg.12349","article-title":"A homozygous mutation in CMAS causes autosomal recessive intellectual disability in a Kazakh family","volume":"84","author":"Qu","year":"2020","journal-title":"Ann. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0610","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41597-023-01960-3","article-title":"Building a knowledge graph to enable precision medicine","volume":"10","author":"Chandak","year":"2023","journal-title":"Sci. Data."},{"issue":"D1","key":"10.1016\/j.ymgme.2024.108434_bb0615","doi-asserted-by":"crossref","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","article-title":"The Reactome pathway knowledgebase","volume":"46","author":"Fabregat","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108434_bb0620","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/cge.14033","article-title":"Epileptic encephalopathy caused by ARV1 deficiency: refinement of the genotype\u2013phenotype spectrum and functional impact on GPI -anchored proteins","volume":"100","author":"Salian","year":"2021","journal-title":"Clin. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108434_bb0625","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3390\/ijms21062028","article-title":"Defects in galactose metabolism and Glycoconjugate biosynthesis in a UDP-glucose Pyrophosphorylase-deficient cell line are reversed by adding galactose to the growth medium","volume":"21","author":"Durrant","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0630","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41467-020-14360-7","article-title":"Loss-of-function mutations in UDP-glucose 6-dehydrogenase cause recessive developmental epileptic encephalopathy","volume":"11","author":"Hengel","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108434_bb0635","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/jimd.12667","article-title":"Beyond genetics: deciphering the impact of missense variants in CAD deficiency","volume":"46","author":"Del Ca\u00f1o-Ochoa","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108434_bb0640","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ajhg.2013.03.012","article-title":"Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation","volume":"92","author":"Ng","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0645","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajhg.2016.12.010","article-title":"Mutations in ATP6V1E1 or ATP6V1A cause autosomal-recessive cutis Laxa","volume":"100","author":"Van Damme","year":"2017","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108434_bb0650","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0887-8994(93)90066-L","article-title":"Low levels of CSF gangliotetraose-series gangliosides in west syndrome: implication of brain maturation disturbance","volume":"9","author":"Izumi","year":"1993","journal-title":"Pediatr. Neurol."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108434_bb0655","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/glia.20503","article-title":"Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers","volume":"55","author":"Susuki","year":"2007","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.ymgme.2024.108434_bb0660","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3390\/biomedicines10071518","article-title":"Start me up: how can surrounding gangliosides affect sodium-potassium ATPase activity and steer towards pathological ion imbalance in neurons?","volume":"10","author":"Puljko","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108434_bb0665","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-011-9370-0","article-title":"How to find and diagnose a CDG due to defective N-glycosylation","volume":"34","author":"Lefeber","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108434_bb0670","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13023-021-01751-2","article-title":"Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history study","volume":"16","author":"Witters","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108434_bb0675","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/diagnostics12061414","article-title":"Quantitation of a urinary profile of biomarkers in Gaucher disease type 1 patients using tandem mass spectrometry","volume":"12","author":"Menkovic","year":"2022","journal-title":"Diagnostics"},{"issue":"11","key":"10.1016\/j.ymgme.2024.108434_bb0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079732","article-title":"Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients","volume":"8","author":"Rolfs","year":"2013","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108434_bb0685","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2017.07.002","article-title":"Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease","volume":"123","author":"Nowak","year":"2018","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922400249X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922400249X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T17:16:22Z","timestamp":1735233382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671922400249X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S109671922400249X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108434","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycosphingolipids in congenital disorders of glycosylation (CDG)","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108434"}}